Multimodal AI to Accelerate Precision Medicine for Type 1 Diabetes (U01- Clinical Trials Not Allowed)
Grant Opportunity Analysis
The National Institutes of Health and the National Institute of Diabetes and Digestive and Kidney Diseases are seeking applications to fund a milestone-driven research project that leverages artificial intelligence to accelerate precision medicine for Type 1 diabetes. Awardees must develop and test advanced multimodal artificial intelligence models, establish AI-enabled research workflows, and create privacy-preserving synthetic datasets to integrate diverse human pancreas and clinical data. This collaborative cooperative agreement aims to uncover new biological insights into disease development, identify biomarkers, and inform novel approaches for diabetes prevention, intervention, and treatment. Total estimated program funding is $5,000,000 to support a single award, with an estimated application closing date of February 10, 2027, and inquiries directed to NIDDK_DEM@nih.gov.
Eligible Applicants
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
Grant Documents
No documents available for this grant.